EMMAC Signs Cannabis Importt Agreement: CC Pharma To Facilitate Products to Germany

EMMAC Life Sciences Ltd (“EMMAC” or the “Organization”), the European autonomous therapeutic cannabis organization, reports that it has entered the German medicinal cannabis advertise through the joining of About Nature Health GmbH (“About Nature”), a completely possessed backup of the Company, which will lead the showcasing and permitting process for EMMAC in Germany. Working related to Medalchemy, EMMAC’s completely authorized GMP affirmed lab and innovative work office in Spain, About Nature has gone into a supply understanding (the “Understanding”) with CC Pharma GmbH (“CC Pharma”), a main merchant and wholesaler of EU-pharmaceuticals for the German market.

The Agreement permits EMMAC to import high caliber dried cannabis blossoms and oils into the quickly growing German market, which is the biggest medicinal cannabis advertise in Europe. As indicated by the Bank of Montreal 1, the German medicinal cannabis market could possibly create more than US$5 billion in income for worldwide cannabis makers, with a suspicion that in seven years, 7.5% of rest, uneasiness and agony solutions in Germany will be supplanted with therapeutic cannabis.

Antonio Costanzo, CEO of EMMAC, remarked: “The choice by CC Pharma to appropriate EMMAC medicinal cannabis item in Germany approves our pledge to conveying the most elevated quality item and we are charmed to declare the Agreement today. Germany is a significant market for EMMAC and we are focused on developing our local nearness, driven by general supervisor, Florian Witt, to guarantee that we gain by the huge business opportunity.

“EMMAC has had a positive begin to 2019 and our entrance into the German market is the most recent critical achievement for the Group. Our tie-up with CC Pharma is an unmistakable show of the critical advancement being made at EMMAC and is reciprocal to the acquisitions finished and key achievements accomplished in 2019 in the UK, Malta, Spain and Switzerland. I anticipate refreshing our partners as we keep on executing on our vision to turn into the main European restorative cannabis organization.”